← USPTO Patent Grants

P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof

Grant US12595261B2 Kind: B2 Apr 07, 2026

Assignee

BEIJING TIDE PHARMACEUTICAL CO., LTD.

Inventors

Yanping Zhao, Hongjun Wang, Yeming Wang, Liying Zhou, Yanan Liu

Abstract

Disclosed are a P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition containing same, and the use thereof for preventing or treating a disease regulated by the P2X3 and/or P2X2/3 receptor antagonist.

CPC Classifications

C07D 471/04 C07D 491/048 C07D 495/04 C07D 498/04 C07D 513/04 A61P 29/00 A61P 11/00 A61K 31/506

Filing Date

2020-06-05

Application No.

17616236

Claims

6

View original document →